Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization
暂无分享,去创建一个
Yimin Huang | J. Maynard | S. Quataert | P. Dubey | A. Fullen | Kacy S. Yount | Jesse M. Hall | Kyle Caution | R. Deora | Mohamed M Shamseldin | Myra Guo | Keirsten Marion | Kyle J Caution